Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
Alcohol-associated liver disease (ALD) is the leading cause of liver disease worldwide, and alcohol-associated hepatitis (AH), a severe form of ALD, is a major contributor to the mortality and morbidity due to ALD. Many factors modulate susceptibility to ALD development and progression, including nu...
Main Authors: | Jeffrey Warner, Josiah Hardesty, Ying Song, Rui Sun, Zhongbin Deng, Raobo Xu, Xinmin Yin, Xiang Zhang, Craig McClain, Dennis Warner, Irina Kirpich |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.711590/full |
Similar Items
-
Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice
by: Jeffrey B. Warner, et al.
Published: (2022-01-01) -
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
by: Jeffrey Warner, et al.
Published: (2020-06-01) -
Dietary fatty acids and bioactive fatty acid metabolites in alcoholic liver disease
by: Kara H. Zirnheld, et al.
Published: (2019-12-01) -
<i>Fpr2</i><sup>−/−</sup> Mice Developed Exacerbated Alcohol-Associated Liver Disease
by: Josiah E. Hardesty, et al.
Published: (2023-04-01) -
Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs
by: Josiah E. Hardesty, et al.
Published: (2021-02-01)